Sign in

CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company

Humacyte, Inc.

Sign in to watch
Ticker
HUMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851763759
Phone
919-313-9633
Business address
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
Former names
Alpha Healthcare Acquisition Corp.
  1. 4 Open-market sale Director sold 699,730 shares at an average $2.78 ($1,945,509)
  2. 4 Open-market sale 10% owner sold 699,730 shares at an average $2.78 ($1,945,509)
  3. 4 Option exercise Chief Operating Officer acquired 6,564 shares (option exercise)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 8-K Event Bylaws or fiscal year change
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 8-K Event Executive or director change · Regulation FD disclosure
  16. 4 Open-market buy President, CEO and Director bought 2,000 shares at $4.14 ($8,280)
  17. 4 Open-market buy Director bought 2,000 shares at $4.14 ($8,280)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. SC 13D/A Stake Beneficial Ownership Report

Page 16 of 26 · 506 filings